Brand name: Neulasta
Pegfilgrastim is a medicine to reduce the risk of infection in some cancer patients receiving myelosuppressive cancer treatments.
It refers to amino acids. It stimulates the bone marrow for the red blood cells production, thus helping to fight infection.